User Name:
Password:
Remember Login:
 
Forgot your password?
 
Or to join, click here.

 












BioHouston thanks our Associate Partners for their support!

Connected Solutions    Ernst & Young    FulBright & Jaworski L.L.P    Mayer Brown           

 
 
 
JOIN BIOHOUSTON

BioHouston is supported annually through corporate memberships.  Membership benefits are myriad—to view membership benefits and join, click here.
 
 
BIOHOUSTON RESOURCE CENTER

The BioHouston Resource Center (BRC) makes it easier and more affordable for start-up companies to get to work producing proof-of-concept data, by providing access to wet lab bench space, shared equipment, and the offices and tools that start-up companies need. For more information, click here.

Your support is needed—for more information, click here.
 
 
HIGHLIGHTS

 
OrthoAccel Technologies, Inc. was the winner of the 2007 Michael E. DeBakey Award and $25,000 cash prize. OrthoAccel Technologies, Inc. designs, develops, and markets a revolutionary device that cuts treatment time for braces in half and works in combination with all existing orthodontia bracket technologies. A panel of venture capitalists awarded OrthoAccel Technologies the DeBakey Life Science Award based on its exceptional potential in commercializing its technology. In addition to the $25,000 cash prize, OrthoAccel received a pro bono provisional patent filing from Baker & McKenzie LLP and premier visibility for the year in all BioHouston programs. To provide further support to the emerging companies that win this award, BioHouston offers winners low cost, short-term office space to help further close the funding gaps typically faced by these companies. OrthoAccel became our newest resident company at the beginning of 2008.
 
 
CURRENT BIOTECH NEWS

VGX Pharmaceuticals Signs Multi-Year Production Agreement with the United Kingdom Cystic Fibrosis Gene Therapy Consortium

KCI's Therapeutic Support Systems Business Announces Agreement with The MED Group

Evestra, Inc., a Drug Company Focused on Women's Health Issues, Launched by Southwest Foundation for Biomedical Research

Repros Therapeutics Inc. Announces That Proellex Shows No Adverse Cardiac Effects In A Pilot Trial

ULURU Inc. Announces the Launch Plan for Altrazeal(TM)

ArthroCare Announces Patients Treated for Chronic Tendinosis with TOPAZ(R) Highly Satisfied Study Shows

LC Sciences and DNAVision form Strategic Marketing Alliance

OncoVista Innovative Therapies Announces Submission of Request for Pre-IDE Determination Meeting with FDA for AdnaGen's AdnaTest Breast Cancer Device for Detection of Circulating Breast Tumor Cells

Kinetic Concepts, Inc. Closes Private Sale of Convertible Senior Notes Due 2015 Pursuant to Full Exercise of Over-Allotment Option Lexicon and BioSeek to Work Together on Drug Discovery

ArthroCare(R) Establishes Direct Sales Representation in Scandinavia

ThromboVision's New Director of Engineering Brings Biotech and Design Background

Lexicon and BioSeek to Work Together on Drug Discovery

President Bush, Congressional Leaders Award DeBakey Nation's Highest Civilian Honor

IDev Technologies Closes $25 Million Financing Round

Asuragen Launches The First Validated microRNA Diagnostic Assay

Asuragen Launches Signature(R) LTx (Leukemia Translocation Panel) Globally

SBIR/STTR Reauthorization Act Approved



 
Save the date! Sponsorship opportunities available...please contact Keisha Curtis at 713.979.9212.
 


Purchase the 2007/2008 Life Science Directory
 
BioHouston